(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

REVMAB BIOSCIENCES

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

REVMAB BIOSCIENCES

ST13

US500000086975709

Class

1

Filing

86975709

Registration

4664916

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

43

Latest update

05/15/2024

Trademark type

Combined

Nice classes

1

Filing date

10/03/2013

Registration date

12/30/2014

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/15/2024

Last transaction

05/15/2024

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/01/2014

First use in commerce

03/01/2014

Drawing code

3

Owner type

03

Owner location

Burlingame, CA, US

Examiner

CROWLEY, PAUL

Law office

M30

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of the wording "RevMAb Biosciences" with the letters "R", "MA", and "B" capitalized. The wording "RevMAb" appears above the word "Biosciences", with the letter "B" placed under the letter "e" in "RevMAb". The letter "v" in "RevMAb" and the first letter "i" in "Biosciences" are formed by a stylized molecular structure that connects the two letters, where each side of the "v" is formed by a parallelogram and the "i" is formed by a six-sided chevron shape coming to a point at the bottom.

Holders and representatives

Holders

RevMAb Biosciences USA, Inc.
RevMAb Biosciences USA, Inc.

Representatives

Muzamil Huq MORRISON & FOERSTER LLP

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Biochemicalsmonoclonal antibodies for research or in vitro research use

Publications

History of USPTO decisions and trademark events.

43 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

05/15/2024

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

05/15/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

05/15/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/15/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

01/29/2024

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

01/03/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/03/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/03/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/03/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

12/30/2023

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

09/24/2020

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

09/23/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/21/2020

E815

TEAS SECTION 8 & 15 RECEIVED

07/16/2020

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/30/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

12/30/2014

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/25/2014

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/24/2014

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

11/08/2014

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/07/2014

DPCC

DIVISIONAL PROCESSING COMPLETE

11/07/2014

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/06/2014

IUAF

USE AMENDMENT FILED

10/09/2014

DRRR

DIVISIONAL REQUEST RECEIVED

10/09/2014

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

10/09/2014

EISU

TEAS STATEMENT OF USE RECEIVED

10/09/2014

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/27/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/01/2014

PUBO

PUBLISHED FOR OPPOSITION

04/01/2014

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/12/2014

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/26/2014

ALIE

ASSIGNED TO LIE

02/24/2014

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/04/2014

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/01/2014

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/31/2014

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/31/2014

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/22/2014

GNRT

NON-FINAL ACTION E-MAILED

01/22/2014

CNRT

NON-FINAL ACTION WRITTEN

01/22/2014

DOCK

ASSIGNED TO EXAMINER

01/17/2014

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

10/11/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/10/2013

NWAP

NEW APPLICATION ENTERED

10/07/2013

Continuous trademark protection

Get notified about every new filing that threatens REVMAB BIOSCIENCES or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.